Christine A Pellizzari's Net Worth
$17.1 Million
Who is Christine A Pellizzari?
Christine A Pellizzari has an estimated net worth of $17.1 Million. This is based on reported shares across multiple companies, which include Science 37 Holdings, Inc., Imunon, Inc., INSMED Inc, Tempest Therapeutics, Inc., Aegerion Pharmaceuticals, Inc., and DENDRITE INTERNATIONAL INC.
SEC CIK
Christine A Pellizzari's CIK is 0001127430
Past Insider Trading and Trends
2021 was Christine A Pellizzari's most active year for acquiring shares with 18 total transactions. Christine A Pellizzari's most active month to acquire stocks was the month of December. 2020 was Christine A Pellizzari's most active year for disposing of shares, totalling 26 transactions. Christine A Pellizzari's most active month to dispose stocks was the month of October. 2015 saw Christine A Pellizzari paying a total of $1,024,200.00 for 60,000 shares, this is the most they've acquired in one year. In 2020 Christine A Pellizzari cashed out on 329,912 shares for a total of $4,788,031.10, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Science 37 Holdings, Inc. (SNCE) No price found
Chief Legal and HR Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -49.69K |
$5.75 | -$285,740.50 |
0
|
Mar 12
| |||
Form 4
| +37.31% | 268.97K |
$0.44 | -$38,093.88 | 989.86K |
Aug 12
| |||
Form 4
| +1.56% | 11.05K |
—
|
—
| 720.88K |
May 19
| |||
Form 4
| +9,364.43% | 702.33K |
—
|
—
| 709.83K |
Apr 28
| |||
Form 4
|
∞
| 5K |
$0.81 | $4,031.50 | 5K |
Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6 - Oct 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Imunon, Inc. (IMNN) Snapshot price: $1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INSMED Inc (INSM) Snapshot price: $71.04
Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.67% | -2.55K |
$26.23 | -$66,781.58 | 149.99K |
May 15
| |||
Form 4
| +8.39% | 11.81K |
—
|
—
| 152.53K |
May 12
| |||
Form 4
|
—
|
0
|
$27.77 | -$729,212.50 | 140.72K |
Scheduled
|
Feb 8 - Feb 9
| ||
Form 4
|
—
|
0
|
$27.08 | -$765,734.00 | 140.72K |
Scheduled
|
Jan 25 - Jan 26
| ||
Form 4
|
—
|
0
|
$25.91 | -$903,500.00 | 140.72K |
Scheduled
|
Jan 20 - Jan 21
| ||
Form 4
| +6.98% | 9.18K |
—
|
—
| 140.72K |
Jan 7
| |||
Form 4
| -1.84% | -2.46K |
$33.32 | -$82,111.06 | 131.54K |
Jan 3 - Jan 4
| |||
Form 4
| +39.70% | 38.08K |
$22.19 | -$2,647,349.35 | 134K |
May 15 - Nov 5
| |||
Form 4
| +36.81% | 25.52K |
$23.75 | -$18,786.25 | 94.87K |
Jan 3
| |||
Form 4
| +62.06% | 25.87K |
—
|
—
| 67.55K |
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| +35.56% | 10.67K |
—
|
—
| 40.67K |
Jan 4
| |||
Form 4
| +50.00% | 10K |
$15.14 | $151,382.00 | 30K |
May 30 - May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
∞
| 20K |
$12.81 | $256,100.00 | 20K |
Dec 14 - Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tempest Therapeutics, Inc. (TPST) Snapshot price: $1.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aegerion Pharmaceuticals, Inc. No price found
EVP, Gen. Counsel & Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||